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Figure 4:  Population image showing different ATGC 
nucleotide sequences3 
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Figure 2:  Height associated genes have shared 
biological connections.  The redder squares indicate 
stronger connections between a gene and its 
predicted biological function.  The genes that are 
highlighted had not previously been associated with 
skeletal growth. These gene variants can be used as a 
shortcut to figuring out which genes are important for 
a specific disease or trait.2 
INTRODUCTION: 
Height is a phenotype, an 
observable trait of the genes that 
we inherit from our parents. It’s a 
polygenic trait, meaning it is 
controlled by 2 or more genes. 
Because it is so easy to measure, it 
is an ideal characteristic to help us 
understand other polygenic traits. 
So far, genome-wide association 
studies (GWAS) have identified 700 
common variants that determine a 
person's height. New discoveries 
have been made by the international 
group called Genetic Investigation of 
Anthropometric Traits (GIANT), 
revealing 83 genetic mutations that 
have additional effects on a person’s 
height1 
CONCLUSION: 
This gives  us a better 
understanding of human 
growth and how these 
variations influence the 
structure of a complex 
polygenic trait.   By identifying 
rare genetic mutations, 
scientists can investigate 
uncommon DNA changes 
involved in other aspects of 
human health, such as diabetes 
and heart disease, giving them 
a better understanding of those 
diseases and may then lead to 
better treatments.  
METHODS: 
Researchers used new technology 
called the Exomechip; this is a 
human genotyping microarray that 
can process thousands of DNA 
samples to identify mutations and 
structural variants.  Common 
variants have a minor allele 
frequency (MAF) of > 5%, and are 
located outside of DNA coding 
regions.  The Exomechip can 
capture low frequency (MAF=1–5%) 
and rare (MAF < 0.5%) variants. 
Because of the identification of 
these mutations, geneticists can 
now account for 27% of the 
genetics determining height, which 
is an increase from 20% based on 
earlier studies.1 
 
 GIANT collaborated with 
Montreal Heart Institute, 
Queen Mary University, 
University of Exeter, UK and 
280 other research groups 
 This study involved over 
700,000 adults:  460,000 
initially and then 250,000 to 
validate the results. 
 Researchers are already 
launching a GWAS of height 
that will include over 2 
million people.1 
Figure 3:  The STC2 gene had  
2 different profoundly rare 
variants; one can be seen in the 
upper left corner.  These very rare 
variants directly alter proteins, 
and have the strongest effects on 
increasing or decreasing height 
by affecting the availability of 
growth factors in the blood.2 
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Figure 1:  Illumina microarray Exomechip3 
